Stockreport

Eli Lilly bets on recombinases in $2.25bn Profluent R&D pact [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF The deal, which will see Lilly hand over an undisclosed upfront payment and funding for Profluent's R&D efforts, could deem the biotech eligible for $2.25bn in developm [Read more]